Business
UBS, Minters help Arrotex in $205m McPherson’s bid – The Australian Financial Review
Rich Lister Ruffy Geminder has got a fight on his hands at ASX-listed beauty company and takeover target McPherson’s.
And while McPhersons board said Gallins offer undervalued the company, it said it would give Arrotex access to due diligence information and progress discussions, with a view to developing a transaction to put to shareholders.
Arrotex was formed in 2019, following the merger of Arrow Pharmaceuticals and Apotex Australia. The company supplies generic pharmaceuticals, over the counter products and vitamins to pharmacies around the country.
Meanwhile, McPhersons supplies health, wellness and beauty…
-
Noosa News22 hours agoMajor crash on Gateway Motorway snarls morning commute
-
Business24 hours agoUp 34% this year, can Challenger shares keep rising according to Macquarie?
-
Business20 hours agoThis ASX 200 mining stock is eyeing the lithium throne
-
General24 hours agoLike ‘déjà vu’ all over again?